Curio Wealth, LLC Novo Cure LTD Transaction History
Curio Wealth, LLC
- $192 Billion
- Q1 2025
A detailed history of Curio Wealth, LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Curio Wealth, LLC holds 1 shares of NVCR stock, worth $17. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1Holding current value
$17% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NVCR
# of Institutions
266Shares Held
78.3MCall Options Held
970KPut Options Held
118K-
Black Rock Inc. New York, NY12.1MShares$217 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$201 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA8.95MShares$160 Million0.03% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT5.52MShares$98.8 Million8.14% of portfolio
-
Capital World Investors Los Angeles, CA5.22MShares$93.3 Million0.02% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.88B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...